Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Avandia Lawsuits Background information on Avandia lawsuits, settlements and litigation updates published between 2008 to 2022. August 20, 2008 Russell Maas Add Your Comments Avandia Lawsuit Overview The Avandia litigation centered on allegations that the diabetes drug rosiglitazone, manufactured by GlaxoSmithKline, increased the risk of heart attacks, strokes, and other serious cardiovascular events. Introduced in the late 1990s as a breakthrough treatment for type 2 diabetes, Avandia quickly became one of the best-selling medications in the world. However, studies later revealed that the drug could significantly elevate the likelihood of cardiac complications, leading to widespread concern among patients, physicians, and regulators about its long-term safety. As evidence mounted, lawsuits were filed nationwide claiming that GlaxoSmithKline knew about Avandia’s cardiovascular risks long before they became public but failed to adequately warn doctors and consumers. Plaintiffs accused the company of concealing unfavorable clinical trial results and misleading the medical community about the drug’s safety profile. The controversy prompted a 2007 U.S. Senate investigation and led the FDA to impose severe restrictions on Avandia’s use while requiring updated warning labels about potential heart-related dangers. Thousands of personal injury and wrongful death lawsuits were eventually consolidated in multidistrict litigation (MDL No. 1871) in the Eastern District of Pennsylvania. After years of litigation and discovery, GlaxoSmithKline reached a $3 billion settlement to resolve the majority of claims. The resolution marked one of the largest pharmaceutical settlements in U.S. history and underscored growing demands for transparency in drug safety testing. Avandia Litigation Updates June 6, 2011: Avandia Litigation Moves Forward for Non-Settled Cases Federal judges overseeing the Avandia multidistrict litigation ordered remaining cases to move forward toward trial after thousands of others had been resolved through settlement. Plaintiffs who declined to participate in prior agreements continued to pursue claims alleging the diabetes drug caused heart attacks and strokes. The order signaled a winding down of one of the largest pharmaceutical MDLs in U.S. history. May 24, 2011: Additional Avandia Lawsuits Settled as Litigation Narrows GlaxoSmithKline reached more settlements to resolve claims that its diabetes medication Avandia caused serious cardiovascular injuries. The drugmaker continued negotiating with attorneys representing individuals who alleged the company misled regulators and the public about known risks. These agreements reduced the number of active lawsuits remaining in federal court. April 18, 2011: Avandia Settlement Negotiations Continue in Federal MDL Settlement discussions continued between GlaxoSmithKline and plaintiffs’ attorneys as the company sought to avoid additional costly trials. The negotiations followed several prior multimillion-dollar resolutions over Avandia heart attack and death claims. Attorneys anticipated more agreements as the MDL neared completion. February 28, 2011: GlaxoSmithKline Settles Off-Label Marketing Claims Over Avandia GSK agreed to pay hundreds of millions of dollars to resolve federal and state investigations alleging illegal off-label marketing of Avandia. The settlement addressed claims that the company promoted the drug for unapproved uses while downplaying cardiovascular risks. It came amid broader scrutiny over pharmaceutical industry marketing practices. December 15, 2010: MDL Court Rules on Avandia Statute of Limitations The federal judge presiding over the Avandia MDL issued a ruling clarifying statute of limitations defenses available to GlaxoSmithKline. The order established criteria for determining when plaintiffs first became aware of their potential claims. The decision had major implications for whether older injury cases could proceed. September 17, 2010: Settlement Negotiations Continue as Avandia Cases Mount As thousands of lawsuits remained pending, GlaxoSmithKline intensified settlement talks to avoid upcoming trials. Reports indicated the company had already resolved several thousand claims over heart-related injuries. Plaintiffs alleged GSK withheld critical cardiovascular data from both the FDA and prescribing physicians. February 24, 2010: Avandia Settlements Announced for More Cases Additional settlements were reached in the Avandia litigation, with GlaxoSmithKline resolving another wave of lawsuits before trial. The drugmaker continued to face allegations that it knew of cardiac risks but delayed issuing proper warnings. The settlements added to a growing total paid to injured patients nationwide. January 25, 2010: GSK Reaches New Round of Avandia Lawsuit Settlements GlaxoSmithKline agreed to resolve several hundred Avandia heart attack lawsuits, reportedly for hundreds of millions of dollars. The settlements followed early trial preparations and mounting negative publicity about the drug’s risks. Attorneys predicted further agreements as bellwether cases approached. October 6, 2009: Thousands of Avandia Settlements Reached Nationwide GlaxoSmithKline settled thousands of pending lawsuits filed by individuals who suffered heart attacks and other cardiovascular events after taking Avandia. The settlements represented a major shift in litigation strategy as the company moved to limit trial exposure. Negotiations remained ongoing for additional unresolved claims. September 15, 2009: Avandia Lawsuit Settlements Begin to Emerge Reports confirmed that GlaxoSmithKline reached early settlements in several Avandia injury lawsuits. The agreements followed pretrial discovery that revealed internal studies highlighting cardiac concerns. The company continued to face thousands of similar claims in both state and federal courts. August 14, 2009: Avandia Liability Estimate Suggests Massive Financial Exposure Analysts estimated GlaxoSmithKline could face billions in liability from the growing number of Avandia heart attack and death claims. The company had already spent hundreds of millions on settlements and legal costs. Investors expressed concern about the long-term financial impact of the litigation. March 20, 2009: Tolling Agreement Approved for Avandia Lawsuits A tolling agreement was approved by the MDL court, pausing certain statute of limitations deadlines while settlement talks proceeded. The measure allowed plaintiffs and defendants more time to negotiate without new filings flooding the system. The order reflected ongoing cooperation between the parties amid complex litigation management. November 20, 2008: California Avandia Lawsuits Sent Back to State Court A group of Avandia cases originally removed to federal court were remanded back to California state courts for trial. The decision was a setback for GSK, which had sought to consolidate proceedings in the MDL. State court judges prepared to move forward with discovery and trial scheduling. August 29, 2008: Website Established for Avandia MDL Updates The U.S. District Court overseeing the Avandia MDL launched an informational website to improve transparency for plaintiffs and attorneys. The site provided access to orders, schedules, and case management updates. The move helped streamline communication across hundreds of coordinated cases nationwide. July 17, 2008: Avandia Trials Expected to Begin Summer 2010 Federal judges managing the Avandia multidistrict litigation announced that the first bellwether trials were expected to begin in mid-2010. The early trial schedule was designed to help evaluate liability and damages across thousands of claims. Plaintiffs’ lawyers viewed the timeline as a critical opportunity to test their cases before juries. Avandia Research and Reports June 2, 2020: New Study Reaffirms Avandia Heart Risk Concerns A new analysis published in 2020 again found that Avandia users faced elevated risks of heart failure and cardiovascular death compared to other diabetes medications. Researchers concluded that the original safety concerns which led to restrictions a decade earlier remained valid. The findings reignited debate over whether the drug should have been reintroduced to the market. June 6, 2013: FDA Panel Votes to Lift Some Avandia Restrictions Following a controversial meeting, an FDA advisory panel voted to ease restrictions on Avandia, arguing that newer studies did not show as severe cardiovascular risks as once believed. Critics warned that loosening oversight could endanger patients given prior evidence of harm. The decision reflected deep divisions within the medical community about the drug’s safety. April 3, 2013: FDA Criticized for Downplaying Avandia Heart Attack Risks A government report accused the FDA of minimizing the severity of Avandia’s heart attack risks in public communications. Lawmakers questioned whether agency officials had succumbed to industry pressure when evaluating post-market data. The report renewed calls for transparency and independent review of pharmaceutical safety decisions. June 13, 2012: FDA Reassessing Avandia Heart Safety Studies The FDA announced a reassessment of prior Avandia studies amid claims that key data were flawed or misrepresented. The review aimed to determine whether cardiovascular risk estimates had been accurately reported. Regulators also sought to restore public trust after years of controversy surrounding the drug’s safety record. September 19, 2010: Avandia Removed From Market Amid Safety Restrictions European regulators suspended sales of Avandia while the FDA sharply restricted its use in the United States. The coordinated action followed years of studies linking the diabetes drug to increased heart attack and stroke risks. The move marked a dramatic conclusion to one of the most contentious drug safety debates in modern history. July 14, 2010: Avandia Restricted in the U.S. Following FDA Review The FDA imposed new prescribing restrictions on Avandia after concluding the drug carried significant cardiovascular risks. Doctors were ordered to reserve it only for patients who could not tolerate other diabetes treatments. The ruling came after extensive review of studies showing increased heart attack rates among users. May 25, 2010: Study Confirms Avandia Heart Risks Remain Elevated A new report published in The New England Journal of Medicine confirmed earlier warnings that Avandia doubled the risk of heart failure and cardiac death. Researchers found no significant benefits over comparable drugs like Actos. The findings added pressure on the FDA to remove the medication from the market. April 15, 2010: Public Citizen Urges Stronger FDA Action Against Avandia The consumer advocacy group Public Citizen criticized the FDA for failing to remove Avandia despite extensive evidence of heart risks. The group cited studies showing increased mortality and hospitalization among patients using the drug. The warning intensified public scrutiny on the agency’s oversight of diabetes treatments. February 23, 2010: FDA Expands Avandia Restrictions After Heart Risk Studies The FDA issued updated warnings limiting Avandia’s use following confirmation of increased heart attack risk. Regulators instructed physicians to avoid prescribing the drug to patients with existing cardiovascular disease. The change marked a turning point in how the agency handled post-market safety signals. December 1, 2009: FDA Investigates Avandia Heart Problem Disclosures Federal investigators began probing GlaxoSmithKline’s handling of data linking Avandia to heart attacks and strokes. Documents suggested that the company had withheld key findings from regulators and physicians. The probe heightened tensions between the manufacturer and public health officials. October 29, 2009: FDA Halts Major Avandia Clinical Trial The FDA suspended a long-term clinical trial involving Avandia after investigators raised ethical concerns over exposing participants to potential cardiac harm. The halt came amid mounting evidence that the drug’s benefits did not outweigh its risks. The decision further damaged confidence in GSK’s diabetes portfolio. September 15, 2009: Recall of Avandia May Be Recommended by Regulators FDA insiders signaled that the agency was considering a full recall of Avandia following analysis of adverse event data showing high rates of heart failure and death. The news prompted physicians to immediately reevaluate treatment options for their patients. Advocacy groups applauded the move as long overdue. August 21, 2009: Avandia Linked to 100,000 Heart Attacks and Injuries A congressional report estimated that Avandia may have contributed to more than 100,000 heart attacks and deaths among U.S. patients. Lawmakers accused GlaxoSmithKline of ignoring internal warnings about cardiovascular risks. The findings fueled growing political pressure for regulatory action. August 5, 2009: Avandia Heart Attack Concerns Delay Study Recruitment Researchers reported difficulty recruiting patients for Avandia trials due to widespread concern about cardiac side effects. Physicians questioned the ethics of testing a drug already linked to severe cardiovascular events. The recruitment delays reflected broader skepticism across the medical community. July 27, 2009: Lawmakers Question FDA’s Decision Not to Recall Avandia Members of Congress held hearings questioning why the FDA had allowed Avandia to remain on the market despite mounting evidence of heart risk. Legislators demanded internal records from both the agency and GlaxoSmithKline. The controversy became one of the most high-profile drug safety debates of the decade. June 19, 2009: FDA May Recommend Avandia Recall Next Month Reports surfaced that FDA safety officials were preparing to recommend a recall of Avandia. The drug’s cardiovascular risk profile had worsened following new post-market data. The news caused sales to plummet as doctors sought alternative diabetes treatments. April 27, 2009: Study Estimates Avandia Death Rate Higher Than Actos A new analysis comparing Actos and Avandia found that Avandia users faced a significantly higher risk of death from cardiac causes. The findings strengthened arguments for withdrawing the drug from the market. The study’s authors warned that safer alternatives were already available. April 10, 2009: Recall Urged by Consumer Watchdog Over Avandia Heart Risks Public Citizen formally petitioned the FDA to recall Avandia, citing overwhelming evidence that it increased heart attack risk. The group accused GSK of hiding safety data and misleading physicians. The petition renewed public calls for swift regulatory action. February 2, 2009: Experts Recommend Ending Avandia Use Due to Heart Risks A panel of researchers concluded that Avandia posed unacceptable cardiovascular risks and should no longer be prescribed. Their recommendation followed mounting data showing a correlation between the drug and heart failure deaths. The findings sparked fresh debate within the medical community. January 13, 2009: Editorial Questions Lack of Avandia Recall Despite Evidence An editorial published in The Lancet criticized regulators for failing to act on extensive data linking Avandia to heart attacks. The authors called the decision to keep the drug on the market a “public health failure.” The commentary intensified scrutiny of both GSK and the FDA. December 15, 2008: Australia Issues Avandia Side Effect Alert Australian health regulators warned physicians to monitor Avandia patients closely for signs of heart problems. The alert mirrored growing concern from U.S. and European agencies. Officials noted an uptick in adverse event reports involving heart failure and stroke. November 24, 2008: FDA Updates Avandia Warning Label The FDA approved stronger label warnings for Avandia to reflect new findings about heart attack and heart failure risks. The agency advised doctors to prescribe the drug only when other medications were ineffective. The update marked one of the first regulatory acknowledgments of Avandia’s cardiovascular dangers. Avandia Lawsuit Examples December 6, 2010: Avandia Class Action Lawsuit Filed in Illinois A class action lawsuit was filed in Illinois against GlaxoSmithKline, alleging the company misled consumers and healthcare providers about Avandia’s heart attack risks. Plaintiffs sought damages for economic losses and medical monitoring. The complaint claimed GSK’s marketing concealed critical safety data for years. February 17, 2010: Utah Lawsuit Filed Over Misleading Avandia Marketing The State of Utah filed a lawsuit accusing GlaxoSmithKline of deceptive marketing practices surrounding Avandia. The complaint alleged that the company promoted the drug as safe and effective despite knowing of its cardiovascular risks. Utah sought restitution for state health programs and penalties for consumer fraud violations. March 16, 2009: California County Files Avandia Lawsuit Over Healthcare Costs Santa Clara County, California, sued GlaxoSmithKline to recover public funds spent treating residents who suffered injuries linked to Avandia. The lawsuit claimed the drugmaker’s failure to disclose heart risk data led to unnecessary hospitalizations and deaths. It was among the first government-led Avandia actions in the United States. March 2, 2008: Avandia Lawsuits Filed on Behalf of 186 Plaintiffs A coordinated filing included 186 individuals who alleged heart attacks, strokes, and deaths caused by Avandia. The plaintiffs claimed GSK knew of cardiovascular dangers long before issuing public warnings. The mass action reflected the rapid expansion of litigation across the country. July 26, 2007: Avandia Class Action Lawsuit Filed in Canada A nationwide class action was launched in Canada on behalf of patients who suffered serious cardiovascular injuries after taking Avandia. The lawsuit accused GlaxoSmithKline of failing to disclose adverse data to Health Canada and the public. It marked one of the earliest international legal actions against the company. July 2, 2007: Avandia Lawsuit Filed Over Permanent Vision Loss A Texas woman filed a lawsuit alleging that Avandia caused her to suffer permanent vision impairment due to fluid buildup in the eye. The complaint asserted that GSK failed to warn doctors about this potential complication. The case highlighted lesser-known side effects beyond the drug’s heart risks. June 12, 2007: Wrongful Death Lawsuit Filed Over Fatal Avandia Heart Attack The family of a man who died from a heart attack filed one of the first wrongful death lawsuits against GlaxoSmithKline. The complaint alleged the company concealed evidence linking Avandia to life-threatening cardiovascular problems. It was an early case that helped spark nationwide litigation over the diabetes drug. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Avandia, Fractures, GlaxoSmithKline, Heart Attack, Stroke More Lawsuit Stories Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 January 15, 2026 Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026 $79 Billion in Class Action Settlements Paid by Corporations in 2025: Report January 15, 2026 29 Comments genny November 14, 2015 really, how long does it take to get the holdback back? my husband did not even have medicare and I have waited 2 years since first check was issued. 2 years is ridiculous!!!!! Sandra May 13, 2013 My Mom started taking Advandi in 2000. She was never sick. She hardly took even an asprin. She was 76. All her brothers and sisters never had chf, heart troubles of any kind. I encouraged her to get checked out because she would fee alittle light headed. The Dr. Luther in the hospitalbecause he wanted to have her examined, her heart and all. They ran all kinds of heart exams, by a cardio Dr. Bloodwork, all. She was a icture of health except for her sugar was a little high. They started her on Advandi. Within 3 mnts, she was on oxygen, within one year, she was having all kinds of medical problems stemming from heart, breathing, weight gain, retaining fuilds,ext. Within 2 years, she was having heart trouble so bad, we almost lost her. Within no time, the bones in her back was fracturing she became very ill. The continued incressing the advandi. In May of2007, her Dr. Dc her advandi. Within 6 weeks my mom was gone. She fractured her arm and hip, an became ichemic, and had several major heartattacks and coded in the hospital. Several dr,s met with all of my family and told us that heart was too weak and they couldn’t do anything to help her. Cardiomyopathi. Chf. Broken bones. Ichemia. She was so fragle. All because of this drug, Advandi, my mom suffered for years and then died a horrible, painful death. I am in one of the class action suit, and from reading all the comments, I am sickened thinking how much more money my family deserves via our mom. Today is Mother’s Day. And because of Advandi, she was taken from us way too soon. vince January 18, 2013 let me just start with 200…….over 200 operations all linked 2 that f”ked up group of them mass murders gay sk & that pill, drug, medication, killer or whatever the shit, is …. back in 2000.,only 5days after taking that trash (i dont even think real trrraaaashhh would treat her as terrible. bullshit aside this f”ked up rollercoster trip took my family & i to hell & back. hear this…. they write something about it having something 2 do with the formula that was put in avandia in mgs. my beautyful rose my mother, ROSALINDA ASTOGRA. left this earth this planet dec. 19, 2008. party with the angels mom!!!! just remember ill get there just alittle fashionably late …. how i wish i could just see, feel your being for a split sec. 2 joe December 29, 2012 Chuck, this is standard practice in all lawsuits, whether medical or class action. General rule is 20% of the settlement. If you don’t have any liens, you will eventually get the 20%. Eric December 28, 2012 I also paid extra to have the attorneys check for Medicare part C, but we knew there was no Part C that paid money out on my behalf.I call my attorney regularly, but no updates. I received some money as I had a heart attack, so can’t we get this moving but the other half is still pending. Plus the cost allowed to check for Part C that I allowed the lawyers to use. This money is in limbo. chuck December 28, 2012 Does anyone know why there HOLDING back money for medicare C in the settlement? gail December 27, 2012 Ronald I too, am wating on the rest of the settlement from the holdback of the medicare. do you know if the lawerys will get a portion of that amount also. This has been just one big old mess, I would rather have my husband back any day than to have to go through with something like this. Glaxo has screwed our deceased loved ones and now us to. Don N November 6, 2012 AS WITH MOST OF YOU MY WIFE DIED FEB. 2009 . MY CLASS ACTION SUIT IS STILL BEENING WORKED ON ronald August 11, 2012 my mother died of chf on july 13 2007 a lot of her illness was a result of avandia we signed a letter with a law firm out of san franciso, they got us a settlement last year[november]. they got their 40% . then we got a littel more last month they got their 40% total in all for us was 12,000 for my mom’s life for this drug. they still have a hold back from medfcare . first it was for part A&B now they have come up with a part C i know she didn’t have part C but they still looking for something to keep this money. lawyer get paid their’s up front but we have to wait Richard July 4, 2012 My mother passed away June 2012. She was put on Avandia in May of 2006. Even though in May of 2007 the risks were published in the New England Journal of Medicine when she first showed symptoms of CHF, her doctor did not take her off Avandia until August of 2008, at which time she already was on full time oxygen and unable to care for herself. My father and mother learned of the Avandia class action suit. Without knowing the settlement outcome, she was asked to sign away her rights to file a law suit on her own while restricted to bed in a healthcare facility in January 2012. My mother died painfully and agonizingly from the effects of CHF on June 13th 2012. On June 14th 2012, she received in the mail a check for a little over $3000.00. This settlement is a reward to GlaxoSmithKline and not to my mother as trading a life for $3000.00 is a deal I am sure a wrongful business would take any day so they can get back to the business of doing business. For the rest of my life, I will never forget the results of what occurred here and to my family. Anita March 21, 2012 my husband took Avandia for 4 years before his doctor took him off of it. now, he has congested heart failure, severe blockages and no hope for recovery. just medication therapy and 24/7 oxygen. i suspect he is one of the cases that will go on to litigation as it has not been settled yet. no word from the attorneys! we call once a month and they tell us nothing. i hope they are fighting for him. any recent news regarding the Avandia settlements? Pat Anthony February 17, 2012 Share information you wish to be published on this page… William February 8, 2012 I suffered a agonizing week in the hospital after having a heart attack w/ 95% blockage in at least 2 veins. I was shocked back to life while in the emergency room and they forgot to put the jelly on the patch on my back. I was in awfull pain from the burn on my back but was glad to be alive. They put in 5 stints and was told they didnt shock me but the evidence was there. some 5 or 6 weeks later I had another heart attack and had to have another stint put in on another vein. I don’t know if I’m getting anything for this attack even though I wasn’t taking the drug at the time I had quit the year before. Now I have an enormous drug and doctor bill I will never get rid of. My Lawyers haven’t gotten me a penny yet nor can they tell me if I will. I hope this company fries for what they have done. Robin T June 11, 2011 I am very interested in finding anyone who has been taking Diclofenac and as a result has had a stroke. My healthy 71 year old father was prescribed this while living in Mazatlan Mexico and went from a 220 lb robust guy to a 150 lb feeble old man in a period of 2 years while taking this medication……which resulted in a stroke. His throat “spasmed” was how he described it and now he has extreme muscle weakness and sleeps 3/4 of the day and has to wear adult diapers because he is afraid he can’t make it to the bathroom. There are many other symptoms these are just a few. He came to live with me several days ago and I stopped giving him this medication immediately. After doing research on the meds he had been prescribed in Mexico…..I wanted to cry …and I did. In just 3 days my father began to improve and carry on an intelligent conversation, infact this morning he made the statement “Today is the first day I feel connected to my body” Josh May 17, 2011 Jim, It’s “their”…but I get what you’re saying….. ramiro May 3, 2011 just take the money Jim S February 16, 2011 Now Glaxo is getting away with paying an average of $46.000 average when analysts say it should have been a half million per case, the crooks just keep making there billion dollars or multi billions per quarter. I just hope they will get there just reward someday. So whatever my settlement ends up, i will be refusing it and taking this matter as far as i can. I am american and I will stand up and make all the waves I can. I had to vent about the crooks a little bit. Everyone have have a nice day and God loves us all.. juana December 30, 2010 Medication that gave me a heart attack 2000.I would like to have information about the law suit. Pat September 23, 2010 I took Avandia for quite a while (and still have lots of it!) but after stopping to use it I had an emergency life-flight to the hospital which necessitated a five bypass open heart surgery. There has never been heart trouble in my family and I consulted a lawfirm about a claim (one that advertised for clients) and was told that they could help me more than a class action suit. However, the day before the class action suit was settled I received my files and a letter from the lawyer telling me to get into the class action suit immediately but they couldn’t help me. Since I thought every-thing was already over because it was too late for me. Consequently, I have never received a penny – but have never completely recovered from the surgery! Angela July 18, 2010 I lost my Mother who was also my best friend to CHF casued no doubt by Avandia her last year of life here on earth was miserable becasue of collapsed vertebra and broken hip which i now know was caused by avandia also. I know we may get some financial compensation from this company but the void in our heart will never be replaced adn those who are living with the health problem caused by the drug will never be healthy again. It is a very very sad situation as a whole. Steve June 12, 2010 I to had Congestive Heart failure while taking Avandia. I also had a quadruple by pass, and had to have a pacemaker-defibulator put in my chest that I have now been told has a bad lead and could go off anytime and shock me to death. I not only blame GSK, but also the FDA for their sloppy research and study of this drug before approving it for sale.I think someone took A LOT OF money under the table to approve this drug. When it should have been flushed down the drain. It has taken alot of my earning years away and has cost me tons other than my insurance has paid. I say electicute the FDA for they are the real killers and ones that have taken so much from me and many others like me and and all I’ll end up with is a few pennys. robert June 2, 2010 congestive heart failure caused me to go from 210 lbs to 267 while taking that dreaded drug. now have macular edema and blockage in heart, and kidney disease. no matter what settlement they reach it cant give me my life back. as one man wrote i once was a hero, now i feel like a zero. thanks gsk for damned near killing me, and there is nothing i can do about it. Manuel March 18, 2009 I have watched on TV several times of a pending law suite. One of the issues was vision. I begin having some blured vision but never related to the medicaton I was taking. Just a concerned paryt that is taking this product!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Leon September 1, 2008 I wish someone had told us about this lethal drug. My wife, Diana, passed away a year ago due to the effects of Avandia. She was only 62 years old and was in good health except for the diabetes Type II that she had contracted some two years earlier. She started complaining to her doctor within a month of taking Avandia that she felt tired, short of breath, and her legs had begun to swell. Within months thereafter she began to gain weight very quickly and her eyesight started to blur. I took her to the Cp Pendleton Naval Hospital and they said she was overweight and that her tests were all borderline. She was having escemic symptoms that were erratic and unexplained. They kept her overnight and released her the next morning. A week later I called the paramedics to take her to the civilian hospitsl in town. She kept saying ” I can’t breath!”. On the fourth day of intensive care, she passed away. The doctor said she died of congestive heart failure, COPD, and PPH. I consulted a lawfirm and consequiently filed a lawsuit against GSK. This suit is awaitng trial under MDL 1871 in U. S. Eastern District Court, Pennsylvania. Avandia Class Action Lawsuit Filed in Canada : AboutLawsuits.com August 29, 2008 […] have had their cases consolidated in a Multidistrict Litigation (MDL) for pretrial proceedings. The Avandia litigation is centralized in the Eastern District of Pennsylvania, where GlaxoSmithKline is […] Australian Alert Issued About Avandia Side Effects : AboutLawsuits.com August 22, 2008 […] PagesAvandia Vision Loss Lawsuit Pending in CanadaAvandia Lawsuits Avandia Wrongful Death Lawsuit Filed in California Avandia Warning Label Updated To Indicate Blood […] Avandia Vision Loss Lawsuit Pending in Canada : AboutLawsuits.com August 20, 2008 […] PagesAvandia Wrongful Death Lawsuit Filed in California Avandia Lawsuits Avandia Warning Label Updated To Indicate Blood Sugar Control Benefits Viagra Could Treat Childhood […] Avandia Wrongful Death Lawsuit Filed in California : AboutLawsuits.com August 14, 2008 […] PagesAvandia Lawsuits Avandia Warning Label Updated To Indicate Blood Sugar Control Benefits Filed Under: News Tags: […] Avandia Warning Label Updated To Indicate Blood Sugar Control Benefits — AboutLawsuits.com July 23, 2008 […] is updating the prescribing information for Avandia to include clinical findings which indicate that users have better glycemic control with the drug […] CommentsThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: yesterday) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025) Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: 2 days ago) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025) Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 3 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)
Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026
Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: yesterday) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025)
Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: 2 days ago) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 3 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)